﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2017v2.3">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2018-09-17T16:46:15-05:00</ReturnTs>
    <TaxPeriodEndDt>2017-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>221732349</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>WISS &amp; COMPANY LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>354 EISENHOWER PARKWAY</AddressLine1Txt>
        <CityNm>LIVINGSTON</CityNm>
        <StateAbbreviationCd>NJ</StateAbbreviationCd>
        <ZIPCd>07039</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2017-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>306068334</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>THE LEANDRO P RIZZUTO FOUNDATION</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>LEAN</BusinessNameControlTxt>
      <PhoneNum>2033519156</PhoneNum>
      <USAddress>
        <AddressLine1Txt>23 BARRY PLACE</AddressLine1Txt>
        <CityNm>STAMFORD</CityNm>
        <StateAbbreviationCd>CT</StateAbbreviationCd>
        <ZIPCd>06902</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>SUSAN RIZZUTO</PersonNm>
      <PersonTitleTxt>TRUSTEE</PersonTitleTxt>
      <PhoneNum>2033519156</PhoneNum>
      <SignatureDt>2018-08-22</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>MICHAEL LAMOTTA</PreparerPersonNm>
      <PTIN>P00041212</PTIN>
      <PhoneNum>9739949400</PhoneNum>
    </PreparerPersonGrp>
    <FilingSecurityInformation>
      <IPAddress>
        <IPv4AddressTxt>50.202.92.18</IPv4AddressTxt>
      </IPAddress>
      <IPDt>2018-08-22</IPDt>
      <IPTm>09:43:24</IPTm>
      <IPTimezoneCd>ED</IPTimezoneCd>
      <FilingLicenseTypeCd>P</FilingLicenseTypeCd>
      <AtSubmissionCreationDeviceId>DA39A3EE5E6B4B0D3255BFEF95601890AFD80709</AtSubmissionCreationDeviceId>
      <AtSubmissionFilingDeviceId>95E3ED7670F1DF5B3CF53D6854EC6A071594F466</AtSubmissionFilingDeviceId>
    </FilingSecurityInformation>
    <TaxYr>2017</TaxYr>
    <BuildTS>2018-06-14 16:35:46Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="14">
    <IRS990PF documentId="RetDoc1235000001" referenceDocumentId="RetDoc2258700001">
      <AddressChangeInd>X</AddressChangeInd>
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>11290514</FMVAssetsEOYAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AnalysisOfRevenueAndExpenses>
        <ContriRcvdRevAndExpnssAmt>7172498</ContriRcvdRevAndExpnssAmt>
        <InterestOnSavRevAndExpnssAmt>1188</InterestOnSavRevAndExpnssAmt>
        <InterestOnSavNetInvstIncmAmt>1188</InterestOnSavNetInvstIncmAmt>
        <CapGainNetIncmNetInvstIncmAmt>0</CapGainNetIncmNetInvstIncmAmt>
        <TotalRevAndExpnssAmt>7173686</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>1188</TotalNetInvstIncmAmt>
        <CompOfcrDirTrstRevAndExpnssAmt>0</CompOfcrDirTrstRevAndExpnssAmt>
        <CompOfcrDirTrstNetInvstIncmAmt>0</CompOfcrDirTrstNetInvstIncmAmt>
        <CompOfcrDirTrstDsbrsChrtblAmt>0</CompOfcrDirTrstDsbrsChrtblAmt>
        <LegalFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002100001">57524</LegalFeesRevAndExpnssAmt>
        <LegalFeesNetInvstIncmAmt>0</LegalFeesNetInvstIncmAmt>
        <LegalFeesDsbrsChrtblAmt>57524</LegalFeesDsbrsChrtblAmt>
        <AccountingFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002200001">25000</AccountingFeesRevAndExpnssAmt>
        <AccountingFeesNetInvstIncmAmt>10000</AccountingFeesNetInvstIncmAmt>
        <AccountingFeesChrtblPrpsAmt>15000</AccountingFeesChrtblPrpsAmt>
        <OtherProfFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002300001">137289</OtherProfFeesRevAndExpnssAmt>
        <OtherProfFeesNetInvstIncmAmt>0</OtherProfFeesNetInvstIncmAmt>
        <OtherProfFeesDsbrsChrtblAmt>137289</OtherProfFeesDsbrsChrtblAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="RetDoc2002500001">59</TaxesRevAndExpnssAmt>
        <TaxesNetInvstIncmAmt>0</TaxesNetInvstIncmAmt>
        <TaxesDsbrsChrtblAmt>0</TaxesDsbrsChrtblAmt>
        <TravConfMeetingRevAndExpnssAmt>65172</TravConfMeetingRevAndExpnssAmt>
        <TravConfMeetingNetInvstIncmAmt>0</TravConfMeetingNetInvstIncmAmt>
        <TravConfMeetingDsbrsChrtblAmt>65172</TravConfMeetingDsbrsChrtblAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="RetDoc2203100001 RetDoc2003200001">16386</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>0</OtherExpensesNetInvstIncmAmt>
        <OtherExpensesDsbrsChrtblAmt>12171</OtherExpensesDsbrsChrtblAmt>
        <TotOprExpensesRevAndExpnssAmt>301430</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>10000</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>287156</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>5954934</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>7456233</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>6256364</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>10000</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>7743389</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>917322</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <CashBOYAmt>6817440</CashBOYAmt>
        <CashEOYAmt>1950</CashEOYAmt>
        <CashEOYFMVAmt>1950</CashEOYFMVAmt>
        <SavAndTempCashInvstEOYAmt>6206285</SavAndTempCashInvstEOYAmt>
        <SavAndTempCashInvstEOYFMVAmt>6206285</SavAndTempCashInvstEOYFMVAmt>
        <AcctRcvblAmt>77000</AcctRcvblAmt>
        <AcctRcvblEOYAmt>77000</AcctRcvblEOYAmt>
        <AcctRcvblEOYFMVAmt>77000</AcctRcvblEOYFMVAmt>
        <OtherInvestmentsBOYAmt>5000000</OtherInvestmentsBOYAmt>
        <OtherInvestmentsEOYAmt referenceDocumentId="RetDoc2018100001">5000000</OtherInvestmentsEOYAmt>
        <OtherInvestmentsEOYFMVAmt>5000000</OtherInvestmentsEOYFMVAmt>
        <LandBldgEquipCostOrOtherBssAmt>11171</LandBldgEquipCostOrOtherBssAmt>
        <LandBldgEquipAccumDeprecAmt>5892</LandBldgEquipAccumDeprecAmt>
        <LandBOYAmt>8999</LandBOYAmt>
        <LandEOYAmt referenceDocumentId="RetDoc2059000001">5279</LandEOYAmt>
        <LandEOYFMVAmt>5279</LandEOYFMVAmt>
        <TotalAssetsBOYAmt>11826439</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>11290514</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>11290514</TotalAssetsEOYFMVAmt>
        <AccountsPayableBOYAmt>31379</AccountsPayableBOYAmt>
        <AccountsPayableEOYAmt>12431</AccountsPayableEOYAmt>
        <GrantsPayableBOYAmt>3882199</GrantsPayableBOYAmt>
        <GrantsPayableEOYAmt>2447900</GrantsPayableEOYAmt>
        <TotalLiabilitiesBOYAmt>3913578</TotalLiabilitiesBOYAmt>
        <TotalLiabilitiesEOYAmt>2460331</TotalLiabilitiesEOYAmt>
        <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
        <UnrestrictedBOYAmt>4295675</UnrestrictedBOYAmt>
        <UnrestrictedEOYAmt>5496111</UnrestrictedEOYAmt>
        <TemporarilyRestrictedBOYAmt>3617186</TemporarilyRestrictedBOYAmt>
        <TemporarilyRestrictedEOYAmt>3334072</TemporarilyRestrictedEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>7912861</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>8830183</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>11826439</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>11290514</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>7912861</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>917322</ExcessRevenueOverExpensesAmt>
        <OtherIncreasesAmt>0</OtherIncreasesAmt>
        <SubtotalAmt>8830183</SubtotalAmt>
        <OtherDecreasesAmt>0</OtherDecreasesAmt>
        <TotNetAstOrFundBalancesEOYAmt>8830183</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <QlfyUndSect4940eReducedTaxGrp>
        <LiableSection4942TaxInd>0</LiableSection4942TaxInd>
        <AdjustedQlfyDistriYr1Amt>6216571</AdjustedQlfyDistriYr1Amt>
        <NetVlNoncharitableAssetsYr1Amt>9514811</NetVlNoncharitableAssetsYr1Amt>
        <DistributionYr1Rt>0.653357</DistributionYr1Rt>
        <AdjustedQlfyDistriYr2Amt>3735457</AdjustedQlfyDistriYr2Amt>
        <NetVlNoncharitableAssetsYr2Amt>5880527</NetVlNoncharitableAssetsYr2Amt>
        <DistributionYr2Rt>0.635225</DistributionYr2Rt>
        <AdjustedQlfyDistriYr3Amt>1540305</AdjustedQlfyDistriYr3Amt>
        <NetVlNoncharitableAssetsYr3Amt>337507</NetVlNoncharitableAssetsYr3Amt>
        <DistributionYr3Rt>4.563772</DistributionYr3Rt>
        <AdjustedQlfyDistriYr4Amt>100200</AdjustedQlfyDistriYr4Amt>
        <NetVlNoncharitableAssetsYr4Amt>198698</NetVlNoncharitableAssetsYr4Amt>
        <DistributionYr4Rt>0.504283</DistributionYr4Rt>
        <AdjustedQlfyDistriYr5Amt>650750</AdjustedQlfyDistriYr5Amt>
        <NetVlNoncharitableAssetsYr5Amt>166601</NetVlNoncharitableAssetsYr5Amt>
        <DistributionYr5Rt>3.906039</DistributionYr5Rt>
        <TotalDistributionRt>10.262676</TotalDistributionRt>
        <AverageDistributionRt>2.052535</AverageDistributionRt>
        <NetVlNoncharitableAssetsAmt>10582777</NetVlNoncharitableAssetsAmt>
        <AdjNetVlNoncharitableAssetsAmt>21721520</AdjNetVlNoncharitableAssetsAmt>
        <NetInvestmentIncomePctAmt>0</NetInvestmentIncomePctAmt>
        <AdjNonchrtblNetInvstIncmPctAmt>21721520</AdjNonchrtblNetInvstIncmPctAmt>
        <QualifyingDistributionsAmt>7743389</QualifyingDistributionsAmt>
      </QlfyUndSect4940eReducedTaxGrp>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>0</InvestmentIncomeExciseTaxAmt>
        <TaxUnderSection511Amt>0</TaxUnderSection511Amt>
        <SubtotalAmt>0</SubtotalAmt>
        <SubtitleATaxAmt>0</SubtitleATaxAmt>
        <TaxBasedOnInvestmentIncomeAmt>0</TaxBasedOnInvestmentIncomeAmt>
        <EstimatedPlusOvpmtIncmTxAmt>0</EstimatedPlusOvpmtIncmTxAmt>
        <ExtsnRequestIncomeTaxPaidAmt>0</ExtsnRequestIncomeTaxPaidAmt>
        <BackupWithholdingWithheldAmt>0</BackupWithholdingWithheldAmt>
        <TotalPaymentsAndCreditsAmt>0</TotalPaymentsAndCreditsAmt>
        <EsPenaltyAmt>0</EsPenaltyAmt>
        <TaxDueAmt>0</TaxDueAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>0</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>0</MoreThan100SpentInd>
        <Form1120POLFiledInd>0</Form1120POLFiledInd>
        <Section4955OrganizationTaxAmt>0</Section4955OrganizationTaxAmt>
        <Section4955ManagersTaxAmt>0</Section4955ManagersTaxAmt>
        <TaxReimbursedAmt>0</TaxReimbursedAmt>
        <ActivitiesNotPreviouslyRptInd>0</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>0</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
        <OrganizationDissolvedEtcInd>0</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>1</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>1</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>AL</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>AR</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>AK</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>CA</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>CO</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>CT</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>DC</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>FL</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>GA</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>HI</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>IL</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>KS</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>KY</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>ME</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>MD</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>MA</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>MN</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>MS</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>NV</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>NH</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>NJ</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>NM</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>NY</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>NC</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>ND</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>OH</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>OK</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>OR</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>PA</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>RI</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>SC</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>TN</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>VA</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>WA</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>WV</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>WI</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>1</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>0</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd referenceDocumentId="RetDoc2089200001">1</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>0</OwnControlledEntityInd>
        <DonorAdvisedFundInd>0</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>1</ComplyWithPublicInspRqrInd>
        <WebsiteAddressTxt>HTTP://ALSFINDINGACURE.ORG</WebsiteAddressTxt>
        <IndividualWithBooksNm>TRUSTEE</IndividualWithBooksNm>
        <PhoneNum>2123733026</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>23 BARRY PLACE</AddressLine1Txt>
          <CityNm>STAMFORD</CityNm>
          <StateAbbreviationCd>CT</StateAbbreviationCd>
          <ZIPCd>06902</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>0</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>0</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>0</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>0</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>0</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>0</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>0</PaymentToGovernmentOfficialInd>
        <UncorrectedPriorActsInd>0</UncorrectedPriorActsInd>
        <UndistributedIncomePYInd>0</UndistributedIncomePYInd>
        <BusinessHoldingsInd>0</BusinessHoldingsInd>
        <JeopardyInvestmentsInd>0</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>0</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>0</InfluenceLegislationInd>
        <InfluenceElectionInd>0</InfluenceElectionInd>
        <GrantsToIndividualsInd>0</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>1</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>0</NoncharitablePurposeInd>
        <TransactionsFailToQlfyAsExcInd>0</TransactionsFailToQlfyAsExcInd>
        <MaintainedExpenditureRspnsInd referenceDocumentId="RetDoc2118100001">1</MaintainedExpenditureRspnsInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>CARL L REISNER</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O PAUL WEISSRIFKIND WHARTON GARR</AddressLine1Txt>
            <AddressLine2Txt>1285 AVENUE OF THE AMERICAS</AddressLine2Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10019</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>SUSAN RIZZUTO</PersonNm>
          <USAddress>
            <AddressLine1Txt>23 BARRY PLACE</AddressLine1Txt>
            <CityNm>STAMFORD</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06902</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>LEANDRO RIZZUTO</PersonNm>
          <USAddress>
            <AddressLine1Txt>23 BARRY PLACE</AddressLine1Txt>
            <CityNm>STAMFORD</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06902</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompOfHghstPdEmplOrNONETxt>NONE</CompOfHghstPdEmplOrNONETxt>
        <OtherEmployeePaidOver50kCnt>0</OtherEmployeePaidOver50kCnt>
        <CompensationOfHghstPdCntrctGrp>
          <PersonNm>MELANIE LEITNER</PersonNm>
          <USAddress>
            <AddressLine1Txt>13 UNION STREET</AddressLine1Txt>
            <CityNm>NEEDHAM</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02494</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>CONSULTING</ServiceTypeTxt>
          <CompensationAmt>95146</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>PAUL WEISS RIFKIND WHARTON &amp; GARRISON LLP</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>1285 AVENUE OF THE AMERICAS</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100196064</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>LEGAL</ServiceTypeTxt>
          <CompensationAmt>80903</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <ContractorPaidOver50kCnt>0</ContractorPaidOver50kCnt>
      </OfficerDirTrstKeyEmplInfoGrp>
      <SumOfProgramRelatedInvstGrp>
        <Expenses1Amt>0</Expenses1Amt>
        <TotalAmt>0</TotalAmt>
      </SumOfProgramRelatedInvstGrp>
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>0</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>5743936</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>5000000</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>10743936</TotalFMVOfUnusedAssetsAmt>
        <ReductionClaimedAmt>0</ReductionClaimedAmt>
        <AcquisitionIndebtednessAmt>0</AcquisitionIndebtednessAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>10743936</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>161159</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>10582777</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>529139</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>529139</MinimumInvestmentReturnAmt>
        <TotalTaxAmt>0</TotalTaxAmt>
        <DistributableBeforeAdjAmt>529139</DistributableBeforeAdjAmt>
        <RecoveriesQualfiedDistriAmt>0</RecoveriesQualfiedDistriAmt>
        <DistributableBeforeDedAmt>529139</DistributableBeforeDedAmt>
        <DeductionFromDistributableAmt>0</DeductionFromDistributableAmt>
        <DistributableAsAdjustedAmt>529139</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <QualifyingDistriPartXIIGrp>
        <ExpensesAndContributionsAmt>7743389</ExpensesAndContributionsAmt>
        <ProgramRelatedInvstTotalAmt>0</ProgramRelatedInvstTotalAmt>
        <QualifyingDistributionsAmt>7743389</QualifyingDistributionsAmt>
        <PctSect4940eOrgNetInvstIncmAmt>0</PctSect4940eOrgNetInvstIncmAmt>
        <AdjustedQualifyingDistriAmt>7743389</AdjustedQualifyingDistriAmt>
      </QualifyingDistriPartXIIGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>529139</DistributableAsAdjustedAmt>
        <UndistributedIncomePYAmt>0</UndistributedIncomePYAmt>
        <TotalForPriorYearsAmt>0</TotalForPriorYearsAmt>
        <ExcessDistributionCyovYr5Amt>642420</ExcessDistributionCyovYr5Amt>
        <ExcessDistributionCyovYr4Amt>90265</ExcessDistributionCyovYr4Amt>
        <ExcessDistributionCyovYr3Amt>1436108</ExcessDistributionCyovYr3Amt>
        <ExcessDistributionCyovYr2Amt>3453668</ExcessDistributionCyovYr2Amt>
        <ExcessDistributionCyovYr1Amt>5740830</ExcessDistributionCyovYr1Amt>
        <TotalExcessDistributionCyovAmt>11363291</TotalExcessDistributionCyovAmt>
        <QualifyingDistributionsAmt>7743389</QualifyingDistributionsAmt>
        <AppliedToYear1Amt>0</AppliedToYear1Amt>
        <AppliedToPriorYearsAmt>0</AppliedToPriorYearsAmt>
        <TreatedAsDistriFromCorpusAmt referenceDocumentId="RetDoc12000100084">50000</TreatedAsDistriFromCorpusAmt>
        <AppliedToCurrentYearAmt>529139</AppliedToCurrentYearAmt>
        <RemainingDistriFromCorpusAmt>7164250</RemainingDistriFromCorpusAmt>
        <ExcessDistriCyovAppCYCorpusAmt>0</ExcessDistriCyovAppCYCorpusAmt>
        <ExcessDistributionCyovAppCYAmt>0</ExcessDistributionCyovAppCYAmt>
        <TotalCorpusAmt>18577541</TotalCorpusAmt>
        <PriorYearUndistributedIncmAmt>0</PriorYearUndistributedIncmAmt>
        <PriorYearDeficiencyOrTaxAmt>0</PriorYearDeficiencyOrTaxAmt>
        <Taxable1Amt>0</Taxable1Amt>
        <Taxable2Amt>0</Taxable2Amt>
        <UndistributedIncomeCYAmt>0</UndistributedIncomeCYAmt>
        <CorpusDistri170b1EOr4942g3Amt>50000</CorpusDistri170b1EOr4942g3Amt>
        <ExcessDistriCyovFromYr5Amt>592420</ExcessDistriCyovFromYr5Amt>
        <ExcessDistriCyovToNextYrAmt>17935121</ExcessDistriCyovToNextYrAmt>
        <ExcessFromYear4Amt>90265</ExcessFromYear4Amt>
        <ExcessFromYear3Amt>1436108</ExcessFromYear3Amt>
        <ExcessFromYear2Amt>3453668</ExcessFromYear2Amt>
        <ExcessFromYear1Amt>5740830</ExcessFromYear1Amt>
        <ExcessFromCurrentYearAmt>7214250</ExcessFromCurrentYearAmt>
      </UndistributedIncomeGrp>
      <SupplementaryInformationGrp>
        <OnlyContriToPreselectedInd>X</OnlyContriToPreselectedInd>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ALS THERAPY DEVELOPMENT INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>300 TECH SQUARE</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02139</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMYLYX PHARMACEUTICALS INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>NGIN WORKPLACE 210 BROADWAY 201</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02139</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IND-ENABLEMENT GRANT</GrantOrContributionPurposeTxt>
          <Amt>225000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BROWN UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>BOX 1911 164 ANGELL STREET</AddressLine1Txt>
            <CityNm>PROVIDENCE</CityNm>
            <StateAbbreviationCd>RI</StateAbbreviationCd>
            <ZIPCd>02912</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>195959</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CEDARS SINAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>6500 WILSHIRE BLVD SUITE 1150</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90048</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>823546</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>DIGNITY HEALTH - ST JOSEPH'S</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ATTN MISC A/R CASH FILE 57431</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>900748781</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>215998</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>EMORY ALS CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>101 WOODRUFF CIRCLE SUITE 6000</AddressLine1Txt>
            <CityNm>ATLANTA</CityNm>
            <StateAbbreviationCd>GA</StateAbbreviationCd>
            <ZIPCd>30322</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>152918</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GE GLOBAL RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 RESEARCH CIRCLE</AddressLine1Txt>
            <CityNm>NISKAYUNA</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>12309</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>154265</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GLADSTONE INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1650 OWENS STREET</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>941582216</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>127779</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JOHNS HOPKINS UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>855 N WOLFE STREET RANGOS 270</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>117978</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>BANK OF AMERICA PO BOX 414876</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02114</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>2517915</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>METHODIST HOSPITAL RESEARCH INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>6670 BERTNER R2-216</AddressLine1Txt>
            <CityNm>HOUSTON</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>77030</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>185571</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TARGET ALS FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 1598 RADIO CITY STATION</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10101</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>450000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE ALS ASSOCIATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1275 K STREET NW SUITE 250</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>275000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE OHIO STATE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1960 KENNY ROAD</AddressLine1Txt>
            <CityNm>COLUMBUS</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>43210</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>103078</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF CALIFORNIA IRVINE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>BIOLOGICAL SCIENCES III 3214 MAIL</AddressLine1Txt>
            <AddressLine2Txt>CODE 4545</AddressLine2Txt>
            <CityNm>IRVINE</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92697</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>111679</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MASS MEDICAL SCHOOL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 LAKE AVE NORTH</AddressLine1Txt>
            <CityNm>WORCESTER</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01655</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>716075</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WASHINGTON UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>115 BIOTECH BLDG BOX 8111 660 S</AddressLine1Txt>
            <AddressLine2Txt>EUCLID</AddressLine2Txt>
            <CityNm>ST LOUIS</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>63110</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.</GrantOrContributionPurposeTxt>
          <Amt>333472</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WEILL CORNELL MEDICAL COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1300 YORK AVENUE BOX 314</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10065</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NONE</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TRANSLATION OF BASIC SCIENCE DISCOVERY TO TREATING PANCREATIC DISEASE</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <TotalGrantOrContriPdDurYrAmt>7456233</TotalGrantOrContriPdDurYrAmt>
        <TotalGrantOrContriApprvFutAmt>0</TotalGrantOrContriApprvFutAmt>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <IntOnSavAndTempCashInvstGrp>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>1188</ExclusionAmt>
        </IntOnSavAndTempCashInvstGrp>
        <SubtotalsIncmProducingActyGrp>
          <UnrelatedBusinessTaxblIncmAmt>0</UnrelatedBusinessTaxblIncmAmt>
          <ExclusionAmt>1188</ExclusionAmt>
          <RelatedOrExemptFunctionIncmAmt>0</RelatedOrExemptFunctionIncmAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>1188</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>0</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>0</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>0</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>0</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>0</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>0</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>0</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>0</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>0</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>0</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <GeneralRuleInd>X</GeneralRuleInd>
      <ContributorInformationGrp>
        <ContributorNum>1</ContributorNum>
        <ContributorPersonNm>LEANDRO P RIZZUTO</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>75 RAPID CREEK ROAD</AddressLine1Txt>
          <CityNm>SHERIDAN</CityNm>
          <StateAbbreviationCd>WY</StateAbbreviationCd>
          <ZIPCd>82801</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>6926337</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>2</ContributorNum>
        <ContributorPersonNm>DENIS RIZZUTO</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>229 BYRAM SHORE ROAD</AddressLine1Txt>
          <CityNm>GREENWICH</CityNm>
          <StateAbbreviationCd>CT</StateAbbreviationCd>
          <ZIPCd>06830</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>100000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>3</ContributorNum>
        <ContributorPersonNm>JOHN DEBAIROS</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>8 SYLVAN AVENUE</AddressLine1Txt>
          <CityNm>WEST NEWTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02465</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>25000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>4</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1Txt>GREENWICH COUNTRY DAY</BusinessNameLine1Txt>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1Txt>401 OLD CHURCH ROAD</AddressLine1Txt>
          <CityNm>GREENWICH</CityNm>
          <StateAbbreviationCd>CT</StateAbbreviationCd>
          <ZIPCd>06830</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>10795</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>5</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1Txt>GREENWICH FILM FESTIVAL</BusinessNameLine1Txt>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1Txt>0 HORSENECK LANE</AddressLine1Txt>
          <CityNm>GREENWICH</CityNm>
          <StateAbbreviationCd>CT</StateAbbreviationCd>
          <ZIPCd>06830</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>40000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>6</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1Txt>THE KAHN FAMILY CHARITABLE FOUNDATION</BusinessNameLine1Txt>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1Txt>21 PIERCE ROAD</AddressLine1Txt>
          <CityNm>WELLESLEY</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02181</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>50000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>7</ContributorNum>
        <ContributorPersonNm>PETER JOAN SECCHIA</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>220 LYON NW SUITE 510</AddressLine1Txt>
          <CityNm>GRAND RAPIDS</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>49503</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>5000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <AccountingFeesSchedule documentId="RetDoc2002200001">
      <AccountingFeesDetail>
        <CategoryTxt>ACCOUNTING FEES</CategoryTxt>
        <Amt>25000</Amt>
        <NetInvestmentIncomeAmt>10000</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>15000</DisbursementsCharitablePrpsAmt>
      </AccountingFeesDetail>
    </AccountingFeesSchedule>
    <AmortizationSchedule documentId="RetDoc2203100001">
      <AmortizationScheduleDetail>
        <AmortizedExpensesDesc>WEBSITE COST</AmortizedExpensesDesc>
        <AcquiredCompletedOrExpendedDt>2016-06-07</AcquiredCompletedOrExpendedDt>
        <AmortizedAmt>11171</AmortizedAmt>
        <DeductionForPriorYearsAmt>2172</DeductionForPriorYearsAmt>
        <AmortizationPeriodRt>36.000000000000</AmortizationPeriodRt>
        <CurrentYearAmortizationAmt>3720</CurrentYearAmortizationAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <TotalAmortizationAmt>5892</TotalAmortizationAmt>
      </AmortizationScheduleDetail>
    </AmortizationSchedule>
    <DistributionFromCorpusElection documentId="RetDoc12000100084">
      <ElectionDesc>PURSUANT TO IRC SECTION 4942(G)(3) AND REG. 53.4942(A)-3, THE FOUNDATION HEREBY ELECTS TO TREAT THE FOLLOWING CURRENT YEAR QUALIFYING DISTRIBUTIONS AS BEING MADE OUT OF CORPUS.TAX YEAR: 12/31/2017AMOUNT: $50,000</ElectionDesc>
    </DistributionFromCorpusElection>
    <ExpenditureResponsibilityStmt documentId="RetDoc2118100001">
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>GENERAL ELECTRIC GLOBAL RESEARCH</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>PNC BANK C/O GENERAL ELECTRIC CO</AddressLine1Txt>
          <AddressLine2Txt>LOCKBOX 645044</AddressLine2Txt>
          <CityNm>PITTSBURGH</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>15219</ZIPCd>
        </USAddress>
        <GrantDt>2014-10-01</GrantDt>
        <GrantAmt>621431</GrantAmt>
        <PurposeOfGrantTxt>RESEARCH GRANT TO ADVANCE THE DEVELOPMENT OF TECHNOLOGY AND SOLUTIONS TO IMPROVE THE CLINICAL UNDERSTANDING AND KNOWLEDGE OF AMYOTROPHIC LATERAL SCLEROSIS.PAYMENTS ARE MADE AT THE BEGINNING OF EACH MILESTONE.ANNUALLY, GE AGREES TO PROVIDE THE CHARITIES WITH FULL AND COMPLETE FINANCIAL REPORTS AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE STATEMENT OF WORK. MRI BRAIN: $235,836PET BRAIN: $110,604NOVEL IMAGING AGENTS: 7,791MULTIOMYX: 123,993</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>478224</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>ONGOING</DatesOfReportsByGranteeTxt>
        <VerificationDt>2018-05-04</VerificationDt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>AMYLYX PHARMACEUTICALS INC</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>NGIN WORKPLACE 210 BROADWAY 201</AddressLine1Txt>
          <CityNm>CAMBRIDGE</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02139</ZIPCd>
        </USAddress>
        <GrantDt>2016-06-06</GrantDt>
        <GrantAmt>750000</GrantAmt>
        <PurposeOfGrantTxt>IND-ENABLING STUDIES TO BRING THERAPEUTIC DIRECTLY TO PATIENTS</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>375000</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>EVERY THREE MONTHS FROM 6/6/2016 OR UPON REQUEST</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
    </ExpenditureResponsibilityStmt>
    <GeneralExplanationAttachment documentId="RetDoc2258700001">
      <GeneralExplanationGrp>
        <IdentifierTxt>MISSION RELATED INVESTMENT</IdentifierTxt>
        <FormAndLineReferenceDesc>990-PF, PART II, LINE 13</FormAndLineReferenceDesc>
        <MediumExplanationTxt>THE FOUNDATION ENTERED INTO A STOCK PURCHASE AGREEMENT WITH A FOR PROFIT ENTITY, EMULATE, INC., PURCHASING 2,000,000 OUT OF 18,000,000 SHARES OF SERIES B PREFERRED STOCK. THE COMPANY CREATED A TECHNOLOGY THAT EMULATES HUMAN BIOLOGY TO AID IN THE UNDERSTANDING OF HOW DISEASES, MEDICINES, CHEMICALS AND FOODS AFFECT HUMAN HEALTH. THE APPLICATION OF SUCH TECHNOLOGY IS EXPECTED TO AID IN THE RESEARCH AND CURE OF DISEASE (INCLUDING ALS), WHICH IS IN FURTHERANCE OF THE FOUNDATION'S EXEMPT PURPOSES.</MediumExplanationTxt>
      </GeneralExplanationGrp>
    </GeneralExplanationAttachment>
    <InvestmentsOtherSchedule2 documentId="RetDoc2018100001">
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>MISSION RELATED INVESTMENT</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>AT COST</ListedAtCostOrFMVCd>
        <BookValueAmt>5000000</BookValueAmt>
        <EOYFMVAmt>5000000</EOYFMVAmt>
      </InvestmentsOtherGrp>
    </InvestmentsOtherSchedule2>
    <LandEtcSchedule2 documentId="RetDoc2059000001">
      <LandEtcGrp>
        <CategoryOrItemTxt>WEBSITE COST</CategoryOrItemTxt>
        <CostOrOtherBasisAmt>11171</CostOrOtherBasisAmt>
        <AccumulatedDepreciationAmt>5892</AccumulatedDepreciationAmt>
        <BookValueAmt>5279</BookValueAmt>
        <EOYFMVAmt>5279</EOYFMVAmt>
      </LandEtcGrp>
    </LandEtcSchedule2>
    <LegalFeesSchedule documentId="RetDoc2002100001">
      <LegalFeesGrp>
        <CategoryTxt>LEGAL FEES</CategoryTxt>
        <LegalFeesAmt>57524</LegalFeesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>57524</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
    </LegalFeesSchedule>
    <OtherExpensesSchedule documentId="RetDoc2003200001">
      <OtherExpensesScheduleGrp>
        <Desc>BUSINESS REGISTRATION FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>12000</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>12000</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>BANK FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>465</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>PAYPAL FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>171</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>171</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>OFFICE EXPENSES</Desc>
        <RevenueAndExpensesPerBooksAmt>30</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>AMORTIZATION</Desc>
        <RevenueAndExpensesPerBooksAmt>3720</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherProfessionalFeesSchedule documentId="RetDoc2002300001">
      <OtherProfessionalFeesDetail>
        <CategoryTxt>CONSULTING FEES</CategoryTxt>
        <Amt>137289</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>137289</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
    </OtherProfessionalFeesSchedule>
    <SubstantialContributorsSch documentId="RetDoc2089200001">
      <SubstantialContributorDetail>
        <PersonNm>LEONARDO P RIZZUTO</PersonNm>
        <USAddress>
          <AddressLine1Txt>75 RAPID CREEK RD</AddressLine1Txt>
          <CityNm>SHERIDAN</CityNm>
          <StateAbbreviationCd>WY</StateAbbreviationCd>
          <ZIPCd>82801</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <BusinessName>
          <BusinessNameLine1Txt>LPR 2012 DISCRETIONARY TRUST</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>75 RAPID CREEK RD</AddressLine1Txt>
          <CityNm>SHERIDAN</CityNm>
          <StateAbbreviationCd>WY</StateAbbreviationCd>
          <ZIPCd>82801</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
      <SubstantialContributorDetail>
        <BusinessName>
          <BusinessNameLine1Txt>NFL FOUNDATION</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>345 PARK AVE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10065</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
    </SubstantialContributorsSch>
    <TaxesSchedule documentId="RetDoc2002500001">
      <TaxesDetail>
        <CategoryTxt>TAXES</CategoryTxt>
        <Amt>59</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>